Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ceramed is a Portuguese biotechnology company specializing in the development and manufacture of advanced bioceramics for bone regeneration. Founded in 2005 as a spin-off from the University of Porto, the company leverages its proprietary Bonelike technology, a synthetic bone graft material that mimics the mineral phase and structural organization of natural bone. This technology facilitates rapid osseointegration and is used across various clinical applications, including orthopedics, dentistry, and maxillofacial surgery. Ceramed's product line, which includes granules, putties, and blocks, is distributed globally and supported by extensive clinical validation. The company is headquartered in Loures, Portugal, and maintains ISO 13485 certification for medical device manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceramed.